Response of patients with IgM and IgA-associated peripheral polyneuropathies to 'off-line' immunoadsorption treatment using the Prosorba® protein a column

Journal of Clinical Apheresis

Volumn 14, Issue 4, 1999, Pages 159-162

  Niemierko, Ewa ^a   Weinstein, Robert ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Apheresis; M component; Paraprotein; Plasma exchange

Indexed keywords

ALPHA INTERFERON; GABAPENTIN; HEPARIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARAPROTEIN; PROTEIN A; WARFARIN;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE COURSE; HUMAN; IMMUNOADSORPTION; MALE; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYNEUROPATHY; TREATMENT OUTCOME;

AGED; DEMYELINATING DISEASES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOSORBENT TECHNIQUES; IMMUNOSORBENTS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PARAPROTEINEMIAS; STAPHYLOCOCCAL PROTEIN A;

EID: 0033384551     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1999)14:4<159::AID-JCA1>3.0.CO;2-Q     Document Type: Article

References (23)

1. Kelly JJ Jr, Kyle RA, O'Brien PC, Dyck PJ. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981;31: 1480-1483.
2. Smith IS, Kahn SN, Lacey BW King RH, Eames RA, Whybrew DJ, Thomas PK. Chronic demyelinating neuropathy associated with benign IgM paraproteinemia. Brain 1983;106:169-195.
3. Osby LE, Noring L, Hast R, Kjellin KG, Knutsson E, Siden A. Benign monoclonal gammopathy and peripheral neuropathy. Br J Haematol 1982;51:531-539.
4. Nobile-Orazio E, Marmiroli P, Baldini L, Spagnol G, Barbieri S, Moggio M, Polli N, Polli E, Scarlato G. Peripheral neuropathy in macroglobulinemia: Incidence and antigen-specificity of M proteins. Neurology 1987;37:1506-1514.
5. Vrethem M, Cruz M, Wen-Xin H, Malm C, Holmgren H, Ernerudh J. Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies. J Neurol Sci 1993;114:193-199.
6. Nemni R, Gerosa E, Piccolo G, Merlini G. Haematologica 1994; 79:557-566.
7. Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med 1998;338:1601-1607.
8. Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991;30:54-61.
9. Latov N. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 1995;37:S32-S42.
10. Weinstein R. Therapeutic apheresis in neurological disorders. J Clin Apheresis 2000;15:(in press).
11. Dyck PJ, Low PA, Winderbank AJ, Jaradeh SS, Gosselin S, Bourque P, Smith BE, Kratz KM, Karnes JL, Evans BA, Pineda AA, O'Brien PC, Kyle RA. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991;325:1482-1486.
12. Weinstein R, Sato PTS, Shelton K, Hartigan N, Ropper AH, Hayes M, Cardillo K. Successful management of paraprotein-associated peripheral polyneuropathies by immunoadsorption of plasma with staphylococcal protein A. J Clin Apheresis 1993;8: 72-77.
13. ® columns. Semin Hematol 1989;26:31S-41S.
14. Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991;30:54-61.
15. Yeung KB, Thomas PK, King RHM, Waddy H, Will RG, Hughes RAC, Gregson NA, Leibowitz S. the clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. J Neurol 1991;238:383-391.
16. Suarez GA, Kelly JJ Jr. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 1993;43:1304-1308.
17. Simovic D, Gorson KC, Ropper AH. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy. Acta Neurol Scand 1998;97: 194-200.
18. Hughes RAC, Newson-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978; 2:750-753.
19. Nilsson IM, Jonsson S, Sundqvist SB, Ahlberg A, Bergentz SE. A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodies. Blood 1981;58:38-44.
20. Langone JJ. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol 1982;32:157-252.
21. Hillson JL, Karr NS, Oppliger IR, Mannik M, Sasso EH. The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med 1993;178:331-336.
22. Huestis DW, Rifkin RM, Durie BGM, Sibley WA, Irani M. An unexpected complication following immunoadsorption with a staphylococcal protein A column. J Clin Apheresis 1992;7:75-77.
23. Cher LM, Hochberg FH, Teruya J, Nitschke M, Valenzuela RF, Schmahmann JD, Herbert M, Rosas HD, Stowell C. Therapy for paraneoplastic neurologic syndromes in six patients with Protein A column immunoadsorption. Cancer 1995;75:1678-1683.